plavix altace
Click on image below to visit plavix Online Page
NEW YORK — A federal judge Tuesday permanently blocked a Canadian maker of a cheap generic version of blood thinner Plavix from marketing the drug, saying its version infringed on a valid patent for Plavix.
U.S. District Judge Sidney H. Stein said Apotex Inc. had failed to prove during a trial in Manhattan that lasted from Jan. 22 through Feb. 15 that the patent was invalid. He said damages will be set in an amount to be determined at future proceedings.
Last year, Stein had granted a request by Sanofi-Aventis, the holder of a patent on Plavix, to stop Apotex from producing the generic drug, which had gained a majority of market share after its launch last summer.
Byline: Joyce Howard Price, THE WASHINGTON TIMES A medical report published online in advance of Food and Drug Administration hearings this week finds that extended use of the anti-clotting drug, Plavix, is linked to a "significant reduction in risk for death or heart attack" in patients implanted with drug-coated stents.
Facts sheet for plavix
Sleep episodes plavix
Pravachol plavix effexor
Plavix vs aspirin
Plavix claritin d
Diflucan plavix
plavix and skin cancer